چاپ صفحه |  صفحه نخست سامانه |  چکیده مقاله |  نویسندگان |  دانلود مقاله | دانشگاه علوم پزشکی تبریز |
| Background: Breast cancer (BC) has been known as the most common type of cancer worldwide and resulted in death among women. BC is usually resistant to standard therapies that are significant problems in managing BC patients. miR-200c belongs to the miRNA family, which is considered as a tumor suppressor with reduced expression levels in various kinds of cancer like BC. Increased expression of miR-200c has been reported as a potent inhibitor of drug resistance and tumor advancement. The purpose of this paper is to examine the outcome of miR-200c restoring on enhancing the BC cells' sensitivity to Doxorubicin through downregulating the MDR1 expression. |
| نویسنده | نفر چندم مقاله |
|---|---|
| سحر صفائی | اول |
| محمد امینی | دوم |
| شیوا نجاری | سوم |
| امیر علی مختارزاده | چهارم |
| نادیا بلندی | پنجم |
| حسین سعیدی | ششم |
| نازیلا علیزاده قراملکی | هفتم |
| دریا جوادرشید | هشتم |
| بهزاد برادران | نهم |
| نام فایل | تاریخ درج فایل | اندازه فایل | دانلود |
|---|---|---|---|
| 619-miR-200c increases the sensitivity of breast cancer cells to Doxorubicin.pdf | 1401/06/14 | 2468717 | دانلود |
